These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19389496)

  • 1. The role of high-dose therapy with autologous stem cell support in the era of novel agents.
    Attal M; Harousseau JL
    Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of autologous stem-cell transplantation in multiple myeloma.
    Attal M; Harousseau JL
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem-cell transplantation for multiple myeloma in the era of novel drugs.
    Bensinger W
    J Clin Oncol; 2008 Jan; 26(3):480-92. PubMed ID: 18056678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination regimens using doxorubicin and pegylated liposomal doxorubicin prior to autologous transplantation in multiple myeloma.
    Moreau P
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):885-90. PubMed ID: 19589027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of allogeneic stem cell transplantation in multiple myeloma.
    Bruno B; Giaccone L; Sorasio R; Boccadoro M
    Semin Hematol; 2009 Apr; 46(2):158-65. PubMed ID: 19389499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous stem cell transplantation in the elderly including pre- and post-treatment options.
    Kumar SK; Hayman SR; Kyle RA
    Bone Marrow Transplant; 2007 Dec; 40(12):1115-21. PubMed ID: 17680019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving transplant options for multiple myeloma: autologous and nonmyeloablative allogenic.
    Gibson J; Ho PJ; Joshua D
    Transplant Proc; 2004 Oct; 36(8):2501-3. PubMed ID: 15561295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple myeloma in the targeted therapy era.
    Saad AA; Sharma M; Higa GM
    Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell transplantation for multiple myeloma: current status and future directions.
    Caldera H; Giralt S
    Curr Hematol Rep; 2004 Jul; 3(4):249-56. PubMed ID: 15217554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.
    Kumar L; Ghosh J; Ganessan P; Gupta A; Hariprasad R; Kochupillai V
    Bone Marrow Transplant; 2009 Mar; 43(6):481-9. PubMed ID: 18978818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma.
    Talamo G; Claxton DF; Dougherty DW; Ehmann CW; Sivik J; Drabick JJ; Rybka W
    Bone Marrow Transplant; 2009 Aug; 44(3):157-61. PubMed ID: 19204716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends in the management of newly diagnosed multiple myeloma.
    Reece DE
    Curr Opin Hematol; 2009 Jul; 16(4):306-12. PubMed ID: 19491669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma.
    Lonial S; Cavenagh J
    Br J Haematol; 2009 Jun; 145(6):681-708. PubMed ID: 19344388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art therapy in multiple myeloma and future perspectives.
    Denz U; Haas PS; Wäsch R; Einsele H; Engelhardt M
    Eur J Cancer; 2006 Jul; 42(11):1591-600. PubMed ID: 16815703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of autologous transplantation in multiple myeloma].
    Pour L; Hájek R; Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 2009 Sep; 55(9):767-72. PubMed ID: 19785373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern treatment options for elderly patients with multiple myeloma.
    Görner M; Späth-Schwalbe E;
    Onkologie; 2008 Jun; 31(6):335-42. PubMed ID: 18547977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular remission of multiple myeloma with cytoreductive autografting followed by a dose-reduced allograft.
    Fujikawa K; Nakaseko C; Cho R; Abe D; Oda K; Tanaka H; Ohwada C; Ozawa S; Takeuchi M; Sakaida E; Shimizu N; Naito M; Nishimura M; Saito Y
    Bone Marrow Transplant; 2007 Nov; 40(10):997-9. PubMed ID: 17724437
    [No Abstract]   [Full Text] [Related]  

  • 19. Frontline treatment in elderly patients with multiple myeloma.
    Facon T; San Miguel J; Mateos MV; Hulin C
    Semin Hematol; 2009 Apr; 46(2):133-42. PubMed ID: 19389497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of transplant in multiple myeloma.
    Barlogie B
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):604-6. PubMed ID: 16167043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.